TY - JOUR
AU - Sticherling, M.
AB - British Journal of Dermatology 2003; 149: 193–227. CORRESPONDENCE Bexarotene reverses alopecia in cutaneous T-cell improved in all five patients, irrespective of the route of lymphoma delivery. Hair regrowth began within 2–9 months and full regrowth was evident by 1Æ5 years. SIR, Mycosis fungoides (MF) is characterized by clonal Patient 1. A 77-year-old Native American woman presen- helper ⁄ memory (CD4+ CD45RO+) T-cells in the epidermis, ted with a 3-month history of a single patch of alopecia whereas follicular mucinosis or alopecia mucinosis has accompanied by pruritus and mild tenderness, generalized perifollicular T-cell infiltrates and may clinically resemble xerosis, fatigue and a 4Æ5-kg unintentional weight loss. 1,2 alopecia areata. Bexarotene is the first retinoid X receptor Asthma and childhood eczema were noted. There was a (RXR)-selective retinoid shown to be effective for cutaneous 4 · 5 cm alopecia areata-like lesion with scaling on the scalp 3,4 T-cell lymphoma. Bexarotene has recently been shown to (Fig. 1a) and macular erythema of less than 1%. An atypical induce T-cell apoptosis in vitro. Although bexarotene oral CD4+ CD8– clonal lymphocytic infiltrate and mucin deposits and topical gel are effective for MF, this is the first report, to were present in the follicular epithelium. 
TI - Juvenile pityriasis rubra pilaris: successful treatment with ciclosporin
JO - British Journal of Dermatology
DO - 10.1046/j.1365-2133.2003.05394.x
DA - 2003-07-01
UR - https://www.deepdyve.com/lp/oxford-university-press/juvenile-pityriasis-rubra-pilaris-successful-treatment-with-LFHjU8OmXs
SP - 202
EP - 203
VL - 149
IS - 1
DP - DeepDyve
ER -